Navigation Links
China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013
Date:6/18/2013

ed by 55.2% to RMB209.3 million ($33.7 million) from RMB134.8 million in the prior year.
  • Interest expense amounted to RMB70.1 million ($11.3 million), compared to RMB3.3 million in the prior year.
  • Net income attributable to the Company amounted to RMB112.4 million ($18.1 million), compared to RMB132.0 million in the prior year.
  • Operating cash inflow for the full year fiscal 2013 was RMB578.6 million ($93.2 million).
  • "Fiscal 2013 was a fruitful year concluded with eventful accomplishments," stated Ms. Ting Zheng, Chief Executive Officer of China Cord Blood Corporation.  "We successfully added 72,228 new subscribers to our subscriber base, finishing the year by surpassing our original target by more than 12%, and our growing accumulated subscriber base exceeded the three hundred thousand mark at 311,982.  These accomplishments were made possible by our years of market cultivation efforts and the 'Dragon Year' baby boom.  Aside from setting new records of revenue and operating cash flow, we have also raised our investment in both Guangdong and Shandong as we continue to expand our presence in China.  In addition, we are pleased that our Beijing subsidiary received AABB Accreditation as our commitment toward high quality standards has been recognized, which motivates us to strive for further quality excellence for our Group as a whole."Summary – The Fourth Quarter and Full Year Ended March 31, 2012 and 2013Three Months Ended March 31,Year Ended March 31,2012201320122013(in thousands)

    RMBRMB

    US$RMBRMB

    US$Revenues

    99,778133,011

    21,417380,490526,123

    84,711Gross Profit

    76,448106,104

    17,085293,832419,502

    67,544Operating Income

    34,84250,747

    8,172134,843209,314

    33,702Net Income Attributable to the
    Company

    29,23923,028

    3,709131,980112,447

    18,106Earnings per Ordinary Shares 
    '/>"/>

    SOURCE China Cord Blood Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related biology technology :

    1. RAPS Opens Offices in Singapore and China
    2. Research Report on Chinas Diabetes Drug Market, 2013-2017
    3. Research Report on Chinas Antidepressant Market, 2013-2017
    4. Research Report on Chinas Anti-Prostatic Hyperplasia (PH) Drug Market, 2013-2017
    5. China Cord Blood Corporation to Report Fourth Quarter and Full Year of Fiscal 2013 Financial Results
    6. Elsevier Signs Strategic Collaboration Agreement with Peoples Medical Publishing House, China
    7. Infinata's BioPharm Insight Global Editor Kim Ha to Moderate Panel at 3rd Annual U.S.-China Conference on Strategies for Mining Profits from Pharma Opportunities in China
    8. China Engineering Plastics Industry will Reach US$5 Million By 2017 - Engineering Plastics Market, Share, Size, Analysis, Market Scale, Competition and Forecast 2013-2017
    9. China Industry Reports: 2013 Research on Swine Industry Chain, Human Tetanus Immunoglobulin, Power Energy Storage Battery and Wind Power Lubricating Grease at ReportsnReports.com
    10. Future Course of New Lethal Avian Flu Outbreak in China Can Be Predicted
    11. China Cord Blood Corporation Received AABB Accreditation
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... ) has announced the addition of Jain PharmaBiotech,s ... Markets and Companies" to their offering. ... markets based on technologies and applications. The report ... basis for estimation of markets. Technologies include array ...
    (Date:9/2/2015)... 02, 2015 ... announced the addition of Jain PharmaBiotech,s new ... Companies" to their offering. ... besides fluorescence in situ hybridization (FISH), comparative ... cytogenetics includes application of nanobiotechnology, microarrays, real-time ...
    (Date:9/2/2015)... , Sept. 2, 2015 Australian prostate ... a prestigious Australian science prize recognising ,outstanding, science that ... track to globally launch a novel prostate cancer diagnostic ... a high level consortium taking out the peer-reviewed Australian ... Scientific Research. This prize is awarded ...
    (Date:9/2/2015)... ZIONA, Israel , September 2, ... TASE: BVXV) today announced the intent of the National Institute ... National Institutes of Health (NIH) within the Department of Health ... trial to be held in the United States ... the use of BiondVax,s universal flu vaccine candidate, Multimeric-001 (M-001), ...
    Breaking Biology Technology:Global Biochips and Microarrays Technologies, Markets and Companies Report 2015 with Market Size in 2014 and Projected Value for the Years 2019 and 2024 2Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 2Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 3Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 3BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3
    ... Oct. 29 MannKind,Corporation (Nasdaq: MNKD ) will ... 5, 2008 at 8:00 a.m. EST., Management of ... the,third quarter financial results, clinical progress and other Company,developments ... from the,Company will be its Chairman and Chief Executive ...
    ... (Nasdaq: SGMO ) today reported third quarter 2008,financial ... September 30, 2008, Sangamo reported a,consolidated net loss of ... loss of $4.3 million, or $0.11 per share, for ... the company had cash, cash equivalents and,investments of $59.5 ...
    ... Pharmaceuticals Inc.,(Nasdaq: TRBN ) today announced that executives ... at two upcoming industry and/or investor,conferences:, -- Nov. ... the,New York Palace Hotel, 455 Madison Ave. in New ... president, is scheduled to present,at 9:55 a.m. EST., ...
    Cached Biology Technology:MannKind Corporation to Hold Third Quarter Financial Results Conference Call on November 5, 2008 2Sangamo BioSciences Reports Third Quarter 2008 Financial Results 2Sangamo BioSciences Reports Third Quarter 2008 Financial Results 3Sangamo BioSciences Reports Third Quarter 2008 Financial Results 4Sangamo BioSciences Reports Third Quarter 2008 Financial Results 5Sangamo BioSciences Reports Third Quarter 2008 Financial Results 6Sangamo BioSciences Reports Third Quarter 2008 Financial Results 7Trubion Announces Presentations at Upcoming Investor Conferences 2
    (Date:8/6/2015)... 2015  Today, U.S. Congressman Mike Honda ... to learn firsthand how Silicon Valley technologies can ... a world leader in multi-factor identity management and ... federal agencies and commercial organizations achieve new levels ... "The vast majority of network breaches can be ...
    (Date:8/5/2015)... August 5, 2015 According to ... Management Market by Software, Services, Vertical (BFSI, Airport, IT & ... - Global Forecast to 2020", published by MarketsandMarkets, defines ... globally into various segments. The global PIAM Market is ... $546.2 Million by 2019, at a CAGR of 14.9 ...
    (Date:8/4/2015)... 2015 Research ... the addition of the "Digital Forensics ... Sub-Segment (Computer Forensics, Network Forensics, Mobile Device ... Vertical and Region - Global Forecast to ... By Component (Hardware, Software, and Service), ...
    Breaking Biology News(10 mins):Rep. Honda to Visit Crossmatch in Redwood City 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2
    ... gene they suspect plays an important role in triggering ... century-and-a-half ago. , And the pathogen that contains this ... the modern world?on the order of billions of dollars ... Avr3a, in a study that appears online in the ...
    ... Created as an alternate route of drug administration to ... skin patches are rapidly becoming an important healthcare product ... of chronic conditions such as angina, hypertension and HRT, ... transdermal patches for a host of new conditions wind ...
    ... Microarray technology can be used to identify each stage ... newly published report. , Melanomas grow in two phases: ... metastasize (spread cancer to other parts of the body) ... a large primary melanoma into radial and vertical portions, ...
    Cached Biology News:Researchers find gene that may be at root of potato blight 2Researchers find gene that may be at root of potato blight 3
    ... ISO 9001:2000 Certified USDA Research Registered OLAW ... Training AALAS Certified Technicians ... GLP Documentation Upon Request Focus ... for all your custom immunology service needs. ...
    biotin-4-fluorescein...
    Human IL-17D Affinity Purified Polyclonal Ab...
    Agar, 5 lb. Bacteriological.Moisture: < 10%, ash: < 6.5%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
    Biology Products: